Ublituximab-Xiyl 150 mg/6 mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 150 mg/6 mL
Reference Brands: Briumvi (USA/EU)
Category: Neurology
ublituximab-xiyl is a CD20-directed monoclonal antibody that targets B-cells responsible for nerve damage in multiple sclerosis. It helps reduce relapses and slow disability progression in adults with relapsing forms of MS. Administered as an intravenous infusion, it offers a targeted approach with fewer infusion sessions compared to some other MS therapies.
Ublituximab-Xiyl — third party manufacturing & bulk supply
Ublituximab-Xiyl 150 mg/6 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ublituximab-Xiyl listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ublituximab-Xiyl →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View Details
Quick Response Guaranteed | Verified Suppliers
